课题基金 / 基金详情

Development of Chemical Models of Cytochrome P450 Aiming Application to Medicinal Chemistry

Development of Chemical Models of Cytochrome P450 Aiming Application to Medicinal Chemistry
细胞色素 P450 化学模型的开发旨在在药物化学中的应用
批准号:
07407079
负责人:
HIGUCHI Tsunehiko
金额:
$3.71万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (A)
财政年份:
1995
资助国家:
日本
项目状态:
已结题
起止时间:
1995 至 1997

项目摘要

项目成果

HIGUCHI Tsunehiko的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
(1) The distinctive structural features of P450 are the unusual thiolate coordination to heme. We have succeeded in the preparation of the first synthetic thiolato-iron porphyrin (SR complex) which can keep its original structure during catalytic oxidation. Experiments using SR,directed toward relative effect of axial ligand, have revealed that a thiolate ligand greatly accelerates the rate of the O-O bond cleavage, and its heterolysis even in highly hydrophobic media. Further, we have established that the thiolate ligand has a marked influence on the reactivity of high-valent iron-oxo porphyrin intermediate.(2) Heteroaromatic N-oxides were found to be excellent oxidants in the presence of ruthenium porphyrin.2,6-Disubstituted pyridine N-oxides plus a catalytic amount of Ru porphyrin oxidized olefins, sulfides, and allyl or benzyl alcohols to afford epoxides, sulfoxides, and aldehydes, respectively, in high yields. The system in the presence of these acids effectively oxidized unactivated alkanes and arenes to give alcohols (or ketones) and p-quinones in high yields with high selectivity and an extremely high catalyst turnover number (up to 1.2 x 10^5). This is the first example that a heteroaromatic N-oxide works as an oxidant for hydrocarbon without photoactivation.(3) P450 mimics were applied to drug metabolism studies. The uses of model systems were effective for one-step preparation of unstable metabolic intermediates, "candidate metabolites", and for the discovery of novel modes of metabolism. In the chemical system, gamma, delta-or beta, gamma-unsaturated carboxylic acids are converted to the delta-or beta-hydroxy-gamma-lactone compound, respectively in high yield with high stereoselectivity.
期刊论文(20)
专著(0)
科研奖励(0)
会议论文
T.Higuchi, C.Satake, M.Hirobe: " "Selective Quinone Formation by Aromatic Oxidation with Heteroaromatic N-Oxide Catalyzed by Ruthenium Porphyrin"" J.Am.Chem.Soc.117. 8879-8880 (1995)
T.Higuchi、C.Satake、M.Hirobe:“钌卟啉催化的杂芳族 N-氧化物芳香氧化选择性醌形成”J.Am.Chem.Soc.117。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Yasuteru Urano: "Pronounced Axial Thiolate LigandEffect on the Reactivity of High-valentOxo-iron Porphyrin Intermediate" Journal of the American ChemicalSociety. 119. 12008-12009 (1997)
Yasuteru Urano:“显着的轴向硫醇盐配体对高价氧代铁卟啉中间体反应性的影响”美国化学会杂志。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Tsunehiko Higuchi: " "Versatile, Highly Efficient Oxidations with Heteroaromatic N-Oxides Catalyzed by Ruthenium Porphyrin"" J.Synth.Org.Chem.Jpn. 53. 633-644 (1995)
樋口恒彦 (Tsunehiko Higuchi):“钌卟啉催化的杂芳族氮氧化物的多功能、高效氧化反应”J.Synth.Org.Chem.Jpn。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
20
    New Strategy for Controlling Activity of Bioactive Compounds by Introduction of Catenane or Rotaxane Structure
    • 批准号:
      23659058
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2011
    • 负责人:
      HIGUCHI Tsunehiko
    • 依托单位:
    Efficient Creation of Drug-functional Molecules with Chemically Evolutional Synthetic Chemistry
    • 批准号:
      20249006
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $26.12万
    • 财政年份:
      2008
    • 负责人:
      HIGUCHI Tsunehiko
    • 依托单位:
    Dynamic Synthesis of Drug-Candidate Molecules Utilizing Cooperative Effect of Integrated Functional Groups
    • 批准号:
      18390039
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.96万
    • 财政年份:
      2006
    • 负责人:
      HIGUCHI Tsunehiko
    • 依托单位:
    Investigation on the Chemical Property of Heme Thiolate Structure and Application to Medicinal Chemistry
    海外基金